We are live on ! Find out more
AAM

Alpine Associates Management Portfolio holdings

AUM $1.6B
1-Year Est. Return 93.19%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+93.19%
3 Year Est. Return
+366.27%
5 Year Est. Return
+1,301.74%
10 Year Est. Return
+22,525.34%
AUM
$1.65B
AUM Growth
-$534M
Cap. Flow
-$575M
Cap. Flow %
-34.89%
Top 10 Hldgs %
61.26%
Holding
66
New
17
Increased
12
Reduced
13
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 24.94%
2 Energy 16.31%
3 Materials 12.46%
4 Financials 10.91%
5 Industrials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
B
26
DELISTED
Barnes Group Inc.
B
$19.5M 1.18%
+412,414
New +$19.2M
PSTX
27
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$19.4M 1.17%
+2,016,700
New +$10.5M
AGS
28
DELISTED
PlayAGS
AGS
$18.9M 1.15%
1,641,317
-60,800
-4% -$704K
SIMO icon
29
Silicon Motion
SIMO
$9.07B
$17.9M 1.08%
330,705
-10,092
-3% -$565K
ARCH
30
DELISTED
Arch Resources, Inc.
ARCH
$15.9M 0.96%
112,569
+51,739
+85% +$7.87M
AZPN
31
DELISTED
Aspen Technology Inc
AZPN
$14.9M 0.9%
+59,700
New +$14.6M
PTVE
32
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$14.3M 0.87%
+820,000
New +$11.1M
INFN
33
DELISTED
Infinera Corporation Common Stock
INFN
$14M 0.85%
1,984,500
-54,200
-3% -$361K
MTTR
34
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$10.6M 0.64%
2,239,182
+193,500
+9% +$918K
PDCO
35
DELISTED
Patterson Companies, Inc.
PDCO
$10.6M 0.64%
+342,874
New +$7.97M
CCRN
36
DELISTED
Cross Country Healthcare
CCRN
$10.6M 0.64%
+581,032
New +$7.82M
IPG
37
DELISTED
Interpublic Group of Companies
IPG
$9.86M 0.6%
+351,800
New +$10.5M
RVNC
38
DELISTED
Revance Therapeutics, Inc.
RVNC
$7.14M 0.43%
2,349,966
-1,812,895
-44% -$7.9M
DESP
39
DELISTED
Despegar.com
DESP
$5.91M 0.36%
+307,000
New +$4.83M
SCWX
40
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$5.27M 0.32%
+623,254
New +$5.2M
PARA
41
DELISTED
Paramount Global Class B
PARA
$4.93M 0.3%
471,000
-17,300
-4% -$186K
ALTM
42
PUT
DELISTED
Arcadium Lithium plc
ALTM
$2.71M 0.16%
+527,800
New +$2.69M
CVE.WS
43
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$1.35M 0.08%
127,258
BA icon
44
Boeing
BA
$184B
-60,900
Closed -$9.26M
CPRI icon
45
Capri Holdings
CPRI
$1.72B
-992,169
Closed -$42.1M
CTLT
46
DELISTED
CATALENT, INC.
CTLT
-2,131,126
Closed -$129M
AY
47
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
-1,662,509
Closed -$36.5M
MRO
48
DELISTED
Marathon Oil Corporation
MRO
-546,572
Closed -$14.6M
HAYN
49
DELISTED
Haynes International, Inc.
HAYN
-501,858
Closed -$29.9M
RCM
50
DELISTED
R1 RCM Inc. Common Stock
RCM
-1,812,300
Closed -$25.7M

Similar funds

Alpine Associates Management's Q4 2024 Portfolio in Review

As of Q4 2024, Alpine Associates Management held 66 positions worth $1.65B, down 24% from $2.18B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Alpine Associates Management withdrew a net $575M in Q4 2024, closing 23 positions and reducing 13 holdings. Its most notable exit was Axonics, Inc. Common Stock, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Energy and Materials.

Against the trend, Alpine Associates Management opened a new position in Berry Global Group, Inc. worth $38.3M.

  • Alpine Associates Management's largest Q4 2024 buy was Berry Global Group, Inc.: 592,600 shares worth $38.3M.
  • Alpine Associates Management added most to Frontier Communications in Q4 2024, an estimated $26.8M increase.
  • Alpine Associates Management's biggest Q4 2024 reduction was Albertsons Companies, cutting an estimated $56.1M.
  • Alpine Associates Management fully exited Axonics, Inc. Common Stock in Q4 2024, selling an estimated $152M.
  • Alpine Associates Management's ten largest holdings make up 61% of its $1.65B portfolio in Q4 2024.
  • Alpine Associates Management opened 17 new positions and closed 23 in Q4 2024.
  • Alpine Associates Management's portfolio value fell 24% quarter-over-quarter to $1.65B.

Based on Alpine Associates Management's 13F filing for Q4 2024, filed 7 Feb 2025.